EBSA#19 Lille survey

Below expectationsAcceptableGoodVery good
Hotel accommodation
Venue / Meeting rooms
Welcom reception
Coffee breaks / lunches
Conference Dinner
Hand out material
Below expectationsAcceptableGoodVery good
Keynote: Louis Pasteur and the microbiological risk (Patrick Berche)
Book presentation (René Courcol)
Parallell session 1: Biosafety of gene therapy (general)
- Replication-competent viruses in cancer gene therapy: biosafety considerations (Rob C. Hoeben)
- Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Gene Therapy (Danielle Horst)
- Environmental risk assessment for gene and cell therapy products: critical issues for CT and MA applications (Ursula Jenal)
Parallell session 2: Working with plants or animals (general)
- EPPO and ensuring plant health in a world without borders (Françoise Petter)
- Taking stock of the environmental risk assessment of GM plants (Patrick Rüdelsheim)
- Keeping them in or out? Control of aerosols in loose housed versus caged laboratory research animals for HPAI studies (Henriette Schubert)
Company prentations (general)
- Risk reduction and best energy savings by membrane air filtration technology for biosafety environments (AAF-Luftechnik)
- Biowaste management: several technologies ... just choose the most convenient for your project! (Actini SAS)
Selection criteria for Effluent Decontamination Systems (PRI Bio)
Best practices and future threaths (Guy Collyer sponsored by BioSAFE engineering)
Biological Safety Cabinets: Simulation and Quantifying of Airflow Perturbation Caused by Personnel Activities presentation (berner international)
Chris Collins Lecture: WHO biosafety manual revision - concept and consequences
Session 3 - Applied biosafety (general)
Impact of EU Biocides Regulation to Biosafety (Heather Sheeley)
Validation of high containment facilities to prove biosafety (Evelien Kampert)
Alternatives to heath inactivation - challenges in demonstrating effectivity (Claudia Bagutti)
Below expectationsAcceptableGoodVery good
Joint training for health threats caused by accidental or intentional release of biological agents (Cornelius Bartels)
Session 4 Applied biosafety (general)
- Validation of a novel contained aerosol transmission system (Simon Parks)
- European Research Infrastructure on Highly-pathogenic Agents (Hervé Raoul)
Session 5 Break-out discussion groups (general)
Break-out 1: DIY Bio (discussion) (Niek D'Hondt)
Break-out 2: Human Assett Management and Safeguarding Science (discussion) (Guy Collyer, Linda van den Berg, André Jacobi)
Break-out 3: Availability of disinfectants for biosafe practices (discussion) (Allan Bennett)
Break-out 4: Risk assessment of cell lines (Tool box) (Otto-Wilhelm Merten, Glynn Stacey)
Break-out 5: Country support strategies for providing joint training or health threats caused by release fo biological agents (Cornelius Bartels, Amanda Ozin-Hofsaeass)
Session 6 Debate session Same problem, new name?
New breeding techniques (Ana Atanassova)
Converting recombinant viruses into genome editing devices (Manuel AFV Gonçalves)
'Risk assessment concerning Synthetic Biology' performed by the European Commission Scientific Committees (Michelle Epstein)
Closing session (general)
Is Zika virus infection a risk for Europe? What we know or don't know (Herve Zeller)